Trauma Product Articles & Analysis
2 news found
Aktiv Pharma Group’s CEO Amir Genosar said, “It is an honor to be able to continue our relationship with BARDA and advance our 2-PAM auto-injector to help support the United States Government’s preparedness mission. We are creating a product that we hope is never used, but when it is needed, we are privileged to be able to provide peace-of-mind with a ...
” Aktiv Pharma Group is a specialty pharmaceutical company, developing drug products in a range of glassfree proprietary pre-filled delivery systems, emphasizing usability, user safety, and drug stability. Aktiv Pharma Group is currently pursuing several new autoinjector products, including trauma treatments that align with the ...